Revvity

Revvity is a global health science solutions provider that transforms the entire research-to-therapy continuum. Leveraging translational multi-omics, biomarker discovery, advanced imaging, predictive analytics, and informatics, the company delivers end-to-end workflows from drug discovery to diagnosis and cure. With over $3 billion in revenue and a workforce of more than 11,000, Revvity partners with pharmaceutical and biotech firms, diagnostic laboratories, academia, and government agencies in more than 190 countries. Its distinctive combination of cutting-edge technology, integrated services, and a culture of turning "impossible" into actionable innovation sets it apart as a leader in the S&P 500-listed life-science sector.